Is Stem Stock a Buy in 2022?
2021 was the year of the special purpose acquisition company (SPAC), but amid the craze of young companies coming public through SPAC mergers, there were many that were money losers for investors. There were even SPACs that brought companies without any revenue to the public markets, and those proceeded to hurt shareholders too.
While the majority of SPAC mergers were not good investments, there were a few potential diamonds in the rough. Stem (NYSE: STEM) is one young company that came public in 2021, and its shares quickly flew up to $50 before falling back around the SPAC price of $10. Does this mean Stem is another forgettable SPAC, or does it have some growth potential over the next decade for patient investors? Let's find out.
Image source: Getty Images.
Source Fool.com
